Get my own profile
Public access
View all6 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Thomas E. Cheatham, IIIProfessor of Medicinal Chemistry; Director Research Computing; University of UtahVerified email at utah.edu
- Ken A. DillDirector of Laufer Center, Stony Brook UniversityVerified email at laufercenter.org
- Rodrigo Galindo-MurilloPrincipal scientist - IONIS Pharmaceuticals, IncVerified email at ionisph.com
- Emiliano BriniSchool of Chemistry and Material Science - RITVerified email at rit.edu
- Alberto PerezUniversity of Florida, Department of ChemistryVerified email at chem.ufl.edu
- Benjamin Bruno, PharmD, PhDSenior Director, Clinical Development, Lipocine Inc.Verified email at pharm.utah.edu
- David W. Woessner, PhDBoehringer IngelheimVerified email at boehringer.com
- Riccardo BaronThe University of UtahVerified email at utah.edu
- Nadeem Ahmad VelloreUniversity of UtahVerified email at utah.edu
- Andrea MatteviProfessor of Molecular Biology, Department of Biology and Biotechnology, University of Pavia.Verified email at unipv.it
- A GanesanProfessor of Chemical Biology, University of East AngliaVerified email at uea.ac.uk